Researcher profile

Ubaka Ogbogu

Ubaka Ogbogu is a Professor and the Associate Dean Research in the Faculty of Law, University of Alberta. He is a Member of the Royal Society of Canada's College of New Scholars, Artists and Scientists (2023 Cohort), the Katz Group Chair in Health Law in the University of Alberta and the Chair of the University of Alberta Research Ethics Board 2. Dr. Ogbogu is a recipient of the Confederation of Alberta Faculty Associations Distinguished Academic Early Career Award. He holds a doctorate in law from the University of Toronto, a Master of Laws degree from the University of Alberta and undergraduate degrees in law from the University of Benin, Nigeria and the Nigerian Law School. Ogbogu’s scholarly work is focused broadly on the ethical, legal and societal implications of novel and emerging biotechnologies and associated research. His publications have explored a diverse range of issues in this field, including the ethical and legal issues associated with stem cell research, gene and engineered cell therapies, biobanks, germline gene editing and assisted reproductive technologies. As a multidisciplinary scholar, his teaching and research activities explore and cut across various fields, including health law, bioethics, science policy, science and technology studies, public health, legal history and legal philosophy. He has led or been involved in many prominent national and international biotechnology policymaking activities and writes and comments frequently in the popular press on matters relating to the impacts of biotechnology and science on society. Ogbogu has served as a member of numerous boards and councils, including the Health Quality Council of Alberta, Council of Canadian Academies Expert Panel on Somatic Gene and Engineered Cell Therapies, the Council of Canadian Academies Expert Panel on Medical Assistance in Dying, the Canadian Institutes of Health Research (CIHR) Stem Cell Oversight Committee, the Canadian Institutes of Health Research Governing Council’s Standing Committee on Ethics, and the International Society for Stem Cell Research Task Force on Guidelines for Stem Cell Research and Clinical Translation.